To invest in basic research means to invest in new ideas, new solutions, and new knowledge and in the continuity of science itself. It is also necessary to strengthen and amplify the national institutions funding technological development. Research activity requires constant financial support and time, given that results cannot be obtained quickly. Anyhow, it is necessary to establish a policy for health-applied biotechnology creating special programs for the development of new drugs, vaccines and diagnostic kits allowing a much more directed allocation of funds, better utilization and better chances to create new products and processes. Another point to be emphasized is the need to amplify the mechanisms for obtaining venture capital, fundamental for the establishment of companies and biotechnological cooperation programs.
Risk capital invested in research is part of a development strategy.
Such investments have surely nothing to do with speculative undertakings, which due to their nature are likely to cause considerable losses at any moment. To find the solution for the Brazilian public health problem is not simple or easy. Adequate management of technology is only one aspect of this complex matter but it would represent a big step on the way. We all know that health is a priority, and we all should join efforts to relieve the situation. The government has thus a great responsibility.